H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 114 Citations 53,161 562 World Ranking 1972 National Ranking 1148

Research.com Recognitions

Awards & Achievements

2012 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

His primary scientific interests are in Genetics, Genome-wide association study, Internal medicine, Single-nucleotide polymorphism and Lung cancer. His research investigates the connection between Genetics and topics such as Immunology that intersect with issues in PTPN22. His research in Genome-wide association study intersects with topics in Primary biliary cirrhosis, Genetic association, Bioinformatics and Genetic predisposition.

His Internal medicine research incorporates elements of Gastroenterology, Oncology and Pathology. His studies deal with areas such as Genotyping and Allele frequency as well as Single-nucleotide polymorphism. His Lung cancer research incorporates themes from Odds ratio, Cancer, Respiratory disease, Lung cancer susceptibility and Nicotine.

His most cited work include:

  • Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network (2762 citations)
  • Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995)) (1460 citations)
  • Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α(1A)-voltage-dependent calcium channel (1377 citations)

What are the main themes of his work throughout his whole career to date?

Christopher I. Amos mainly focuses on Genetics, Internal medicine, Genome-wide association study, Oncology and Single-nucleotide polymorphism. Gene, Genotype, Allele, Locus and Genetic linkage are the subjects of his Genetics studies. Internal medicine is represented through his Lung cancer, Cancer, Odds ratio, Case-control study and Colorectal cancer research.

His study in Genome-wide association study is interdisciplinary in nature, drawing from both Genetic predisposition, Bioinformatics, Expression quantitative trait loci, Genetic association and Computational biology. His work deals with themes such as Risk factor, Pathology, Proportional hazards model, Hazard ratio and Breast cancer, which intersect with Oncology. The study incorporates disciplines such as Genotyping, Immunology and Haplotype in addition to Single-nucleotide polymorphism.

He most often published in these fields:

  • Genetics (43.27%)
  • Internal medicine (35.82%)
  • Genome-wide association study (30.18%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (35.82%)
  • Oncology (28.75%)
  • Genome-wide association study (30.18%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Oncology, Genome-wide association study, Cancer and Lung cancer. His Oncology study which covers Colorectal cancer that intersects with Disease. Christopher I. Amos combines subjects such as Allele, Genetic association and Genetic predisposition with his study of Genome-wide association study.

His Cancer research is multidisciplinary, incorporating perspectives in Penetrance, Germline mutation and Cohort. In his research, Locus is intimately related to Adenocarcinoma, which falls under the overarching field of Lung cancer. His Single-nucleotide polymorphism research is within the category of Genetics.

Between 2018 and 2021, his most popular works were:

  • Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2. (113 citations)
  • The Human Tumor Atlas Network: Charting Tumor Transitions Across Space and Time at Single-Cell Resolution (65 citations)
  • Novel Common Genetic Susceptibility Loci for Colorectal Cancer (57 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Christopher I. Amos focuses on Internal medicine, Oncology, Genome-wide association study, Lung cancer and Cancer. His study ties his expertise on Allele together with the subject of Internal medicine. The concepts of his Oncology study are interwoven with issues in Incidence, Polymorphism, Ovarian cancer, Proportional hazards model and Breast cancer.

His Genome-wide association study research is multidisciplinary, incorporating elements of Medical genetics, Genetic association and Genetic predisposition. His Lung cancer research includes themes of Mendelian randomization, Confidence interval, Lung cancer susceptibility, Genetic variation and Adenocarcinoma. His Cancer study deals with the bigger picture of Genetics.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger.
Nature (2014)

3773 Citations

Erratum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (Nature Genetics (2009) 41 (991-995))

Xifeng Wu;Yuanqing Ye;Lambertus A. Kiemeney;Patrick Sulem.
Nature Genetics (2009)

2177 Citations

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

H Kitchener;A M C Swart;Q Qian.
The Lancet (2009)

1897 Citations

Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α(1A)-voltage-dependent calcium channel

Olga Zhuchenko;Jennifer Bailey;Penelope Bonnen;Tetsuo Ashizawa;Tetsuo Ashizawa.
Nature Genetics (1997)

1767 Citations

A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.

Ann B. Begovich;Victoria E H Carlton;Lee A. Honigberg;Steven J. Schrodi.
American Journal of Human Genetics (2004)

1726 Citations

GERMLINE MUTATIONS IN THE EXTRACELLULAR DOMAINS OF THE 55 KDA TNF RECEPTOR, TNFR1, DEFINE A FAMILY OF DOMINANTLY INHERITED AUTOINFLAMMATORY SYNDROMES

Michael F McDermott;Ivona Aksentijevich;Jérôme Galon;Elizabeth M McDermott.
Cell (1999)

1370 Citations

Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1

Christopher I. Amos;Xifeng Wu;Peter Broderick;Ivan P. Gorlov.
Nature Genetics (2008)

1298 Citations

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

Eli A Stahl;Soumya Raychaudhuri;Soumya Raychaudhuri;Elaine F Remmers;Gang Xie.
Nature Genetics (2010)

1270 Citations

STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus

Elaine F. Remmers;Robert M. Plenge;Annette T. Lee;Robert R. Graham;Robert R. Graham.
The New England Journal of Medicine (2007)

1174 Citations

TRAF1–C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study

Robert M. Plenge;Mark Seielstad;Leonid Padyukov;Annette T. Lee.
The New England Journal of Medicine (2007)

983 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Christopher I. Amos

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 237

Qingyi Wei

Qingyi Wei

Duke University

Publications: 232

Stephen J. Chanock

Stephen J. Chanock

National Institutes of Health

Publications: 201

Xifeng Wu

Xifeng Wu

The University of Texas MD Anderson Cancer Center

Publications: 179

Jenny Chang-Claude

Jenny Chang-Claude

German Cancer Research Center

Publications: 168

Roger L. Milne

Roger L. Milne

Cancer Council Victoria

Publications: 167

Margaret R. Spitz

Margaret R. Spitz

The University of Texas MD Anderson Cancer Center

Publications: 159

Peter Kraft

Peter Kraft

Harvard University

Publications: 141

Jane Worthington

Jane Worthington

Manchester Academic Health Science Centre

Publications: 141

Paul D.P. Pharoah

Paul D.P. Pharoah

University of Cambridge

Publications: 139

John Blangero

John Blangero

The University of Texas at Austin

Publications: 135

Peter K. Gregersen

Peter K. Gregersen

Feinstein Institute for Medical Research

Publications: 128

Wei Zheng

Wei Zheng

Vanderbilt University Medical Center

Publications: 126

John L. Hopper

John L. Hopper

University of Melbourne

Publications: 124

Hong-Wen Deng

Hong-Wen Deng

Tulane University

Publications: 124

Douglas F. Easton

Douglas F. Easton

University of Cambridge

Publications: 123

Something went wrong. Please try again later.